id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-D-0179-0002,FDA,FDA-2004-D-0179,Guidance for Industry Changes to an Approved NDA or ANDA; Specifications - Use of Enforcement Discretion for Compendial Changes,Other,Guidance,2004-11-23T05:00:00Z,2004,11,,,2024-11-12T04:12:13Z,,1,0,09000064804701de
FDA-2004-D-0179-0001,FDA,FDA-2004-D-0179,FDA,Notice,NAD-Notice of Availability of Data,2004-11-23T05:00:00Z,2004,11,2004-11-22T05:00:00Z,2005-11-23T04:59:59Z,2008-04-12T00:34:45Z,,0,0,09000064804701dc